BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,329,278 | -29.4% | 35,222 | -14.8% | 0.01% | -20.0% |
| Q2 2023 | $1,882,403 | -2.7% | 41,317 | -13.4% | 0.02% | -6.2% |
| Q1 2023 | $1,934,347 | -36.6% | 47,691 | -20.3% | 0.02% | -40.7% |
| Q4 2022 | $3,051,829 | -39.3% | 59,875 | -35.8% | 0.03% | -42.6% |
| Q3 2022 | $5,026,000 | -35.2% | 93,320 | -22.7% | 0.05% | -28.8% |
| Q2 2022 | $7,759,000 | -56.6% | 120,794 | -47.6% | 0.07% | -47.6% |
| Q1 2022 | $17,862,000 | -93.1% | 230,360 | -92.4% | 0.13% | -91.3% |
| Q4 2021 | $258,602,000 | +5.4% | 3,012,607 | -1.2% | 1.45% | +0.3% |
| Q3 2021 | $245,352,000 | -3.3% | 3,050,499 | -3.2% | 1.45% | -3.1% |
| Q2 2021 | $253,629,000 | -5.9% | 3,150,667 | -1.4% | 1.50% | -12.9% |
| Q1 2021 | $269,616,000 | -5.4% | 3,196,769 | -10.0% | 1.72% | -9.7% |
| Q4 2020 | $285,145,000 | -3.5% | 3,553,650 | -3.3% | 1.90% | -10.4% |
| Q3 2020 | $295,629,000 | +12.1% | 3,676,061 | +20.0% | 2.12% | +6.9% |
| Q2 2020 | $263,689,000 | +2.1% | 3,062,591 | -3.7% | 1.98% | -5.8% |
| Q1 2020 | $258,224,000 | +10122.6% | 3,180,491 | +10430.4% | 2.11% | +13068.8% |
| Q4 2019 | $2,526,000 | -7.7% | 30,203 | -3.5% | 0.02% | -11.1% |
| Q3 2019 | $2,738,000 | -8.1% | 31,303 | -13.9% | 0.02% | -10.0% |
| Q2 2019 | $2,979,000 | -4.4% | 36,376 | -5.1% | 0.02% | -4.8% |
| Q1 2019 | $3,115,000 | +9.1% | 38,315 | -11.7% | 0.02% | -4.5% |
| Q4 2018 | $2,856,000 | -4.1% | 43,386 | +12.4% | 0.02% | +22.2% |
| Q3 2018 | $2,977,000 | +4.4% | 38,611 | 0.0% | 0.02% | +5.9% |
| Q2 2018 | $2,851,000 | +16.8% | 38,611 | +2.9% | 0.02% | +21.4% |
| Q1 2018 | $2,441,000 | -0.8% | 37,526 | -1.5% | 0.01% | 0.0% |
| Q4 2017 | $2,461,000 | +4.0% | 38,080 | +0.9% | 0.01% | +7.7% |
| Q3 2017 | $2,367,000 | -10.5% | 37,728 | -13.7% | 0.01% | -7.1% |
| Q2 2017 | $2,646,000 | +3.8% | 43,700 | -11.1% | 0.01% | 0.0% |
| Q1 2017 | $2,550,000 | -28.5% | 49,174 | -38.8% | 0.01% | -26.3% |
| Q4 2016 | $3,565,000 | -9.4% | 80,397 | -2.8% | 0.02% | -9.5% |
| Q3 2016 | $3,937,000 | +0.4% | 82,712 | -4.7% | 0.02% | +5.0% |
| Q2 2016 | $3,923,000 | -33.0% | 86,749 | -39.1% | 0.02% | -33.3% |
| Q1 2016 | $5,854,000 | -84.6% | 142,499 | -85.7% | 0.03% | -85.0% |
| Q4 2015 | $37,936,000 | +5.0% | 994,399 | -9.6% | 0.20% | +8.7% |
| Q3 2015 | $36,145,000 | -95.2% | 1,100,299 | -89.8% | 0.18% | -94.8% |
| Q2 2015 | $757,921,000 | +0.1% | 10,838,277 | -2.0% | 3.55% | +3.5% |
| Q1 2015 | $757,411,000 | -6.7% | 11,057,090 | -0.2% | 3.43% | +0.2% |
| Q4 2014 | $811,646,000 | -4.4% | 11,074,445 | -6.4% | 3.42% | 0.0% |
| Q3 2014 | $849,446,000 | -1.1% | 11,835,673 | -0.3% | 3.42% | -1.7% |
| Q2 2014 | $858,654,000 | -2.5% | 11,876,261 | -0.8% | 3.48% | -7.5% |
| Q1 2014 | $881,103,000 | +7.6% | 11,974,766 | +1.7% | 3.76% | +1.8% |
| Q4 2013 | $818,588,000 | +14.7% | 11,769,778 | +8.3% | 3.70% | +9.4% |
| Q3 2013 | $713,827,000 | -3.1% | 10,866,607 | +2.2% | 3.38% | -3.1% |
| Q2 2013 | $736,434,000 | -9.8% | 10,631,361 | -5.4% | 3.49% | -17.3% |
| Q1 2013 | $816,636,000 | – | 11,242,229 | – | 4.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |